PTI | , Hindustan Times, New Delhi
PUBLISHED ON JUN 01, 2021 03:48 AM IST
- Cipla requests government for indemnification and exemptions from price capping, bridging trials and basic customs duty.
PTI | , New Delhi
PUBLISHED ON MAY 26, 2021 04:06 AM IST
While Moderna has conveyed to Indian authorities that it does not have surplus vaccines to share in 2021, there are limited prospects of Johnson & Johnson exporting its jabs from the US to other countries in the near future, the people added.
Written by Prashasti Singh, Hindustan Times, New Delhi
PUBLISHED ON MAY 25, 2021 07:08 AM IST
The Covid-19 detection kit is approved by the ICMR (Indian Council of Medical Research) and uses multiplex PCR technology.
By hindustantimes.com | Edited by Karan Manral, New Delhi
PUBLISHED ON MAY 24, 2021 11:48 AM IST
In a joint statement with Cipla, Roche India said that the second batch of the Covid-19 drug will be made available by mid-June. The cost of each dose, the statement said, will be ₹59,750.
PUBLISHED ON MAY 15, 2021 08:22 PM IST
Cipla, one of India's oldest drug manufacturers, has a deal to make and supply remdesivir to more than 100 countries.
Livemint | By Neetu Chandra Sharma, New Delhi
PUBLISHED ON MAY 11, 2021 07:00 AM IST
These voluntary licensing pacts will ensure high-quality manufacturing and accessibility of baricitinib during the pandemic, improving the local treatment options available to those battling by the deadly infection, the company said in a statement.
Reuters | , Bengaluru
PUBLISHED ON MAY 10, 2021 10:05 AM IST
In November, the US Food and Drug Administration initially gave Eli Lilly an emergency use approval for baricitinib in combination with Remdesivir to treat Covid-19 patients.
PUBLISHED ON APR 13, 2021 02:02 PM IST
India has overtaken Brazil as the world's second-worst coronavirus-hit country after the United States, having administered about 107 million vaccine doses among a population of 1.4 billion.
Hindustan Times, New Delhi | By Rhythma Kaul
UPDATED ON DEC 16, 2020 11:36 AM IST
This is the pharma major’s second launch in the diagnostics space after Elifast which is a test kit to detect antibodies against the virus that causes Covid-19
Hindustan Times, Mumbai | By Prashant Singh
UPDATED ON NOV 24, 2020 01:56 PM IST
Buoyed by his successes and boy-next-door appeal, Ayushmann Khurrana is the new blue-eyed-boy of the ad world; the actor feels what has worked for him is swimming against the tide and ‘being totally myself’
Hindustan Times, Mumbai | By Faisal Malik, Mumbai
UPDATED ON JUL 11, 2020 01:45 AM IST
State home minister Anil Deshmukh and food and drug administration (FDA) minister Dr Rajendra Shingne held a meeting on Friday to regulate the distribution remdesivir and tocilizumab following complaints of the drugs being illegally hoarded and traded in the black market.
Hindustan Times, New Delhi | By Anonna Dutt
UPDATED ON JUL 09, 2020 01:17 AM IST
Doctors blame increased demand and limited supply of the medicine for its shortage since the Union health ministry on June 13 allowed its emergency use for treating Covid-19 patients with moderate symptoms.
Bengaluru | By Reuters | Posted by Kanishka Sarkar
UPDATED ON JUN 25, 2020 01:11 PM IST
India has approved the generic versions made by Cipla and Hetero for restricted emergency use in severe Covid-19 cases.
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Sohini Sarkar
UPDATED ON JUN 22, 2020 03:36 PM IST
Remdesivir, happens to be the only USFDA approved Emergency Use Authorisation (EUA) treatment for adults and children hospitalised with suspected or laboratory confirmed coronavirus infection.